OBJECTIVE: To estimate work loss days due to absenteeism and presenteeism associated with commonly occurring mental and physical disorders. METHODS: In a nationally representative face-to-face survey (Netherlands Mental Health Survey and Incidence Study-2) including 4,715 workers, the presence of 13 mental and 10 chronic physical disorders was assessed using the Composite International Diagnostic Interview 3.0 and a physical disorder checklist. Questions about absent days due to illness and days of reduced quantitative and qualitative functioning while at work were based on the WHO Disability Assessment Schedule. Total work loss days were defined as the sum of the days of these three types of loss, where days of reduced functioning were counted as half. Both individual and population-level effects of disorders on work loss were studied, taking comorbidity into account. RESULTS: Any mental disorder was associated with 10.5 additional absent days, 8.0 days of reduced-qualitative functioning and 12.0 total work loss days. For any physical disorder, the number of days was 10.7, 3.5 and 11.3, respectively. Adjusted for comorbidity, drug abuse, bipolar disorder, major depression, digestive disorders and panic disorder were associated with the highest number of additional total work loss days. At population-level, major depression, chronic back pain, respiratory disorders, drug abuse and digestive disorders contributed the most. Annual total work loss costs per million workers were estimated at <euro>360 million for any mental disorder; and <euro>706 million for any physical disorder. CONCLUSIONS: Policies designed to lessen the impact of commonly occurring disorders on workers will contribute to a reduction in absenteeism and presenteeism. As the indirect costs of (mental) disorders are much higher than their medical costs, prevention and treatment of these conditions may be cost-effective.
OBJECTIVE: To estimate work loss days due to absenteeism and presenteeism associated with commonly occurring mental and physical disorders. METHODS: In a nationally representative face-to-face survey (Netherlands Mental Health Survey and Incidence Study-2) including 4,715 workers, the presence of 13 mental and 10 chronic physical disorders was assessed using the Composite International Diagnostic Interview 3.0 and a physical disorder checklist. Questions about absent days due to illness and days of reduced quantitative and qualitative functioning while at work were based on the WHO Disability Assessment Schedule. Total work loss days were defined as the sum of the days of these three types of loss, where days of reduced functioning were counted as half. Both individual and population-level effects of disorders on work loss were studied, taking comorbidity into account. RESULTS: Any mental disorder was associated with 10.5 additional absent days, 8.0 days of reduced-qualitative functioning and 12.0 total work loss days. For any physical disorder, the number of days was 10.7, 3.5 and 11.3, respectively. Adjusted for comorbidity, drug abuse, bipolar disorder, major depression, digestive disorders and panic disorder were associated with the highest number of additional total work loss days. At population-level, major depression, chronic back pain, respiratory disorders, drug abuse and digestive disorders contributed the most. Annual total work loss costs per million workers were estimated at <euro>360 million for any mental disorder; and <euro>706 million for any physical disorder. CONCLUSIONS: Policies designed to lessen the impact of commonly occurring disorders on workers will contribute to a reduction in absenteeism and presenteeism. As the indirect costs of (mental) disorders are much higher than their medical costs, prevention and treatment of these conditions may be cost-effective.
Authors: Michael Von Korff; Paul Crane; Michael Lane; Diana L Miglioretti; Greg Simon; Kathleen Saunders; Paul Stang; Nancy Brandenburg; Ronald Kessler Journal: Pain Date: 2005-02 Impact factor: 6.961
Authors: Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler Journal: Int J Methods Psychiatr Res Date: 2006 Impact factor: 4.035
Authors: J Alonso; G Vilagut; S Chatterji; S Heeringa; M Schoenbaum; T Bedirhan Üstün; S Rojas-Farreras; M Angermeyer; E Bromet; R Bruffaerts; G de Girolamo; O Gureje; J M Haro; A N Karam; V Kovess; D Levinson; Z Liu; M E Medina-Mora; J Ormel; J Posada-Villa; H Uda; R C Kessler Journal: Psychol Med Date: 2010-06-16 Impact factor: 7.723
Authors: J Alonso; M C Angermeyer; S Bernert; R Bruffaerts; T S Brugha; H Bryson; G de Girolamo; R Graaf; K Demyttenaere; I Gasquet; J M Haro; S J Katz; R C Kessler; V Kovess; J P Lépine; J Ormel; G Polidori; L J Russo; G Vilagut; J Almansa; S Arbabzadeh-Bouchez; J Autonell; M Bernal; M A Buist-Bouwman; M Codony; A Domingo-Salvany; M Ferrer; S S Joo; M Martínez-Alonso; H Matschinger; F Mazzi; Z Morgan; P Morosini; C Palacín; B Romera; N Taub; W A M Vollebergh Journal: Acta Psychiatr Scand Suppl Date: 2004
Authors: J Alonso; M Petukhova; G Vilagut; S Chatterji; S Heeringa; T B Üstün; A O Alhamzawi; M C Viana; M Angermeyer; E Bromet; R Bruffaerts; G de Girolamo; S Florescu; O Gureje; J M Haro; H Hinkov; C-y Hu; E G Karam; V Kovess; D Levinson; M E Medina-Mora; Y Nakamura; J Ormel; J Posada-Villa; R Sagar; K M Scott; A Tsang; D R Williams; R C Kessler Journal: Mol Psychiatry Date: 2010-10-12 Impact factor: 15.992
Authors: Mark J Edlund; Jiantong Wang; Kristen Gulledge Brown; Valerie L Forman-Hoffman; Sara L Calvin; Sarra L Hedden; Jonaki Bose Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-06-29 Impact factor: 4.328
Authors: Benjamin B Lahey; Robert F Krueger; Paul J Rathouz; Irwin D Waldman; David H Zald Journal: Psychol Bull Date: 2016-12-22 Impact factor: 17.737
Authors: Fenna Leijten; Swenneke van den Heuvel; Goedele Geuskens; Jan Fekke Ybema; Astrid de Wind; Alex Burdorf; Suzan Robroek Journal: J Occup Rehabil Date: 2013-03
Authors: Frederick W Thielen; Margreet Ten Have; Ron de Graaf; Pim Cuijpers; Aartjan Beekman; Silvia Evers; Filip Smit Journal: Eur Child Adolesc Psychiatry Date: 2016-05-06 Impact factor: 4.785
Authors: Gabriela Barbaglia; Margreet ten Have; Saskia van Dorsselaer; Jordi Alonso; Gemma Vilagut; Ron de Graaf Journal: Qual Life Res Date: 2014-09-18 Impact factor: 4.147
Authors: Dianne L Chambless; Barbara Milrod; Eliora Porter; Robert Gallop; Kevin S McCarthy; Elizabeth Graf; Marie Rudden; Brian A Sharpless; Jacques P Barber Journal: J Consult Clin Psychol Date: 2017-06-26
Authors: A Antunes; D Frasquilho; S Azeredo-Lopes; M Silva; G Cardoso; J M Caldas-de-Almeida Journal: Epidemiol Psychiatr Sci Date: 2018-08-06 Impact factor: 6.892
Authors: Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker Journal: BMC Psychiatry Date: 2014-07-02 Impact factor: 3.630